Conclusion: It is suggested that MIF gene-modified tumor vaccine can induce specific antitumor immune responses mediated by T cells and may be a candidate for gene therapy of tumor.

• 结论：MIF基因修饰的瘤苗能诱导T细胞介导的抗肿瘤免疫反应，有可能作为肿瘤基因治疗的候选者。